Showing results (271-280 of 740) with videos related to
Sort By:
Pageof 74
Journal of Hepatology|November 3, 2001
Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosisD Azoulay, D Castaing, P Majno, et al.The Journal of Clinical Investigation|April 1, 1992
Reinfection of liver graft by hepatitis C virus after liver transplantationC Féray, D Samuel, V Thiers, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver GroupJ Devlin, P Wong, R Williams, et al.Journal De Chirurgie|August 1, 1989
[Cyclosporin, toxicity and efficacy in rejection of liver allografts in the rat]A Settaf, J Gugenheim, M K Lahlou, et al.Transplantation|February 1, 1988
Relationship between the liver and lymphocytotoxic alloantibodies in inbred rats. Specific absorption by nonparenchymal liver cellsJ Gugenheim, B Le Thai, P Rouger, et al.Hepatology (Baltimore, Md.)|April 1, 1995
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazidF Durand, J Bernuau, D Pessayre, et al.Transplantation|April 27, 1995
The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patientsO Farges, A N Kalil, D Samuel, et al.Gastroenterology|April 1, 1995
Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantationC Féray, M Gigou, D Samuel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognosesJ F Emile, D Azoulay, J M Gornet, et al.Immunopharmacology and Immunotoxicology|March 1, 1993
In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21N Sadeg, C Pham-Huy, P Rucay, et al.Pageof 74